NASA awards $899,787 contract to Encapsulate Inc. for AI-driven metastasis prediction research

Contract Overview

Contract Amount: $899,787 ($899.8K)

Contractor: Encapsulate Inc.

Awarding Agency: National Aeronautics and Space Administration

Start Date: 2025-07-16

End Date: 2027-07-15

Contract Duration: 729 days

Daily Burn Rate: $1.2K/day

Competition Type: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES

Number of Offers Received: 500

Pricing Type: FIRM FIXED PRICE

Sector: R&D

Official Description: PHASE II SBIR - 80NSSC25C0036 NVASIVE: AN AI AND MACHINE LEARNING APPROACH FOR METASTASIS PREDICTION USING NVASIVE AND MICROGRAVITY

Place of Performance

Location: FARMINGTON, HARTFORD County, CONNECTICUT, 06032

State: Connecticut Government Spending

Plain-Language Summary

National Aeronautics and Space Administration obligated $899,787 to ENCAPSULATE INC. for work described as: PHASE II SBIR - 80NSSC25C0036 NVASIVE: AN AI AND MACHINE LEARNING APPROACH FOR METASTASIS PREDICTION USING NVASIVE AND MICROGRAVITY Key points: 1. Contract focuses on advanced AI and machine learning for metastasis prediction, a critical area in medical research. 2. The award is a Phase II SBIR, indicating a focus on small business innovation and technology maturation. 3. Research aims to leverage invasive and microgravity data, suggesting novel approaches to understanding cancer spread. 4. The contract duration of 729 days allows for substantial development and testing of the proposed AI models. 5. This award aligns with NASA's broader interest in life sciences research and potential dual-use applications. 6. The firm fixed-price contract structure shifts performance risk to the contractor, Encapsulate Inc.

Value Assessment

Rating: good

The contract value of $899,787 for a Phase II SBIR is within a reasonable range for specialized R&D projects. Benchmarking against similar AI/ML research contracts within NASA or other agencies would provide further context on value for money. The firm fixed-price nature suggests a defined scope, but the novelty of the AI application means potential for cost overruns if unforeseen technical challenges arise.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under 'FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES,' which implies an initial exclusion of sources followed by a broader competition. While the specific details of the exclusion are not provided, the subsequent full and open competition suggests a competitive process was ultimately employed. The number of bidders is not specified, but the 'full and open' nature generally promotes a wider range of proposals.

Taxpayer Impact: A full and open competition, even with prior exclusions, is generally favorable for taxpayers as it increases the likelihood of receiving competitive pricing and innovative solutions.

Public Impact

The primary beneficiaries are researchers and medical professionals who will gain access to advanced AI tools for predicting cancer metastasis. The research delivered will be an AI and machine learning model capable of predicting metastasis. The geographic impact is national, with potential for global adoption of the technology in cancer research and treatment. Workforce implications include potential job creation in AI development, data science, and biomedical research sectors.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Positive Signals

Sector Analysis

This contract falls within the Research and Development sector, specifically focusing on physical, engineering, and life sciences. The market for AI in healthcare and biomedical research is rapidly expanding, with significant investment in developing predictive models for diseases like cancer. NASA's involvement highlights the potential for space-related research to yield terrestrial benefits, particularly in life sciences.

Small Business Impact

As a Phase II SBIR award, this contract is specifically designed to support small business innovation. Encapsulate Inc. is likely a small business that has successfully progressed from Phase I. The success of this project could lead to further commercialization and subcontracting opportunities, fostering the growth of the small business in the R&D ecosystem.

Oversight & Accountability

Oversight will likely be managed by the National Aeronautics and Space Administration (NASA) program managers responsible for this research area. Accountability measures are tied to the firm fixed-price contract terms and deliverables. Transparency is facilitated through the Federal Procurement Data System (FPDS) and potential public reporting of research findings, though specific oversight details are not provided.

Related Government Programs

Risk Flags

Tags

research-and-development, artificial-intelligence, machine-learning, small-business-innovation-research, phase-ii-sbir, nasa, national-aeronautics-and-space-administration, firm-fixed-price, full-and-open-competition, life-sciences, cancer-research, connecticut

Frequently Asked Questions

What is this federal contract paying for?

National Aeronautics and Space Administration awarded $899,787 to ENCAPSULATE INC.. PHASE II SBIR - 80NSSC25C0036 NVASIVE: AN AI AND MACHINE LEARNING APPROACH FOR METASTASIS PREDICTION USING NVASIVE AND MICROGRAVITY

Who is the contractor on this award?

The obligated recipient is ENCAPSULATE INC..

Which agency awarded this contract?

Awarding agency: National Aeronautics and Space Administration (National Aeronautics and Space Administration).

What is the total obligated amount?

The obligated amount is $899,787.

What is the period of performance?

Start: 2025-07-16. End: 2027-07-15.

What is the specific technical approach Encapsulate Inc. will use to develop the AI and machine learning model for metastasis prediction?

The provided data does not detail the specific technical approach. However, as a Phase II SBIR, the project likely builds upon preliminary research from Phase I. The mention of 'invasive and microgravity' data suggests the model may analyze cellular or tissue responses under specific conditions, potentially simulating aspects of cancer cell behavior in different environments. The AI/ML component would involve training algorithms on these datasets to identify patterns indicative of metastatic potential. Further details would typically be found in the proposal or subsequent technical reports.

How does the $899,787 contract value compare to typical Phase II SBIR awards in the R&D sector?

The contract value of $899,787 is within the upper range for a Phase II SBIR award, which can vary significantly. Phase II awards typically range from $500,000 to $1.5 million, focusing on the R&D needed to explore the feasibility and potential commercial applications of an innovation. This award suggests a project of substantial scope and complexity, requiring significant investment to mature the technology. Benchmarking against specific R&D sub-sectors like AI or biomedical research would provide more precise comparisons.

What are the key performance indicators (KPIs) or milestones expected for this contract?

Specific KPIs and milestones are not detailed in the provided data. However, for a Phase II SBIR focused on AI/ML development, typical milestones would include data acquisition and preprocessing, model development and training, validation of model performance against benchmark datasets, prototype demonstration, and potentially a final report detailing findings and commercialization pathways. Performance would likely be assessed based on the accuracy, sensitivity, and specificity of the metastasis prediction model.

What is Encapsulate Inc.'s track record with government contracts, particularly SBIR awards?

The provided data indicates this is a Phase II SBIR award (80NSSC25C0036), suggesting Encapsulate Inc. has likely completed or is completing a Phase I SBIR. Without access to a comprehensive contract database, their broader track record with government contracts, including other SBIR phases or different agencies, cannot be determined from this snippet alone. Further research would be needed to assess their history of performance and successful delivery on prior awards.

What are the potential risks associated with the 'FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES' award type?

The 'FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES' (FOUCAES) award type can introduce complexities. It implies that initially, certain sources were excluded, possibly due to specific requirements or prior relationships, before the opportunity was opened to full and open competition. While the latter part ensures broader participation, the initial exclusion might raise questions about fairness or whether the most innovative solutions were considered from the outset. The specific reasons for the initial exclusion would be crucial for a complete risk assessment.

How does this contract align with NASA's broader strategic goals in life sciences and technology development?

This contract aligns with NASA's strategic goals by advancing research in life sciences, particularly in areas with potential terrestrial applications. NASA's mission includes understanding biological systems and leveraging space environments for research. Developing advanced AI for medical prediction contributes to this by pushing the boundaries of data analysis and potentially improving health outcomes. Furthermore, SBIR programs are a key mechanism for NASA to foster innovation and support the commercialization of technologies developed through its research initiatives.

Industry Classification

NAICS: Professional, Scientific, and Technical ServicesScientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Product/Service Code: RESEARCH AND DEVELOPMENTGeneral Science and Technology R&D Services

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Offers Received: 500

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Address: 400 FARMINGTON AVENUE, FARMINGTON, CT, 06032

Business Categories: Category Business, Limited Liability Corporation, Manufacturer of Goods, Partnership or Limited Liability Partnership, Self-Certified Small Disadvantaged Business, Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $899,787

Exercised Options: $899,787

Current Obligation: $899,787

Actual Outlays: $156,250

Contract Characteristics

Multi-Year Contract: Yes

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: NO

Timeline

Start Date: 2025-07-16

Current End Date: 2027-07-15

Potential End Date: 2027-07-15 00:00:00

Last Modified: 2026-04-09

Other National Aeronautics and Space Administration Contracts

View all National Aeronautics and Space Administration contracts →

Explore Related Government Spending